公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 GRIFOLS BRASIL LTDA取消

154 记录

产品持有公司班级有效性
Weak D Control80134860329GRIFOLS BRASIL LTDAIV16/11/2036
Anti-K Mono-Type Dual80134860330GRIFOLS BRASIL LTDAIV16/11/2036
Anti-A1 Lectin Dual80134860331GRIFOLS BRASIL LTDAIII16/11/2036
Anti-H Mono-Type80134860324GRIFOLS BRASIL LTDAIII08/09/2036
Anti-H for DG Gel80134860323GRIFOLS BRASIL LTDAIII10/08/2036
ID CORE XT Reagents80134860219GRIFOLS BRASIL LTDAIV04/07/2036
PROCLEIX ULTRIO ELITE Assay80134860220GRIFOLS BRASIL LTDAIV04/07/2036
DG GEL NEUTRAL80134860099GRIFOLS BRASIL LTDAIV15/05/2036
DG Gel Newborn80134860154GRIFOLS BRASIL LTDAIV28/03/2036
DG Gel Anti-IgG80134860155GRIFOLS BRASIL LTDAIII28/03/2036
Procleix Plasmodium Assay Calibrators80134860322GRIFOLS BRASIL LTDAIV16/03/2036
DG GEL CT80134860088GRIFOLS BRASIL LTDAIV06/02/2036
DG GEL ANTI-D80134860089GRIFOLS BRASIL LTDAIV06/02/2036
DG GEL ABO/Rh80134860094GRIFOLS BRASIL LTDAIV06/02/2036
DG GEL NEUTRAL/COOMBS80134860097GRIFOLS BRASIL LTDAIII06/02/2036
DG GEL DC Scan80134860098GRIFOLS BRASIL LTDAIV06/02/2036
DG GEL CONFIRM80134860090GRIFOLS BRASIL LTDAIV30/01/2036
DG GEL ABO/Rh (2D)80134860091GRIFOLS BRASIL LTDAIV30/01/2036
DG GEL COOMBS80134860092GRIFOLS BRASIL LTDAIII30/01/2036
Extended IV Control80134860213GRIFOLS BRASIL LTDAIV03/11/2035
Essential II Control80134860214GRIFOLS BRASIL LTDAIV03/11/2035
DG Gel Rh Pheno80134860143GRIFOLS BRASIL LTDAIV21/09/2035
Discriminatory Probe Reagent kit (Procleix UltrioPlex E)80134860320GRIFOLS BRASIL LTDAIV15/09/2035
DG Gel Rh Pheno+Kell80134860139GRIFOLS BRASIL LTDAIV13/09/2035
DG Gel Confirm P80134860141GRIFOLS BRASIL LTDAIV13/09/2035

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家